{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:01:06Z","timestamp":1762542066747},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,4,25]],"date-time":"2012-04-25T00:00:00Z","timestamp":1335312000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00277-012-1468-4","type":"journal-article","created":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T01:37:19Z","timestamp":1335231439000},"page":"1245-1250","source":"Crossref","is-referenced-by-count":18,"title":["Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concerns"],"prefix":"10.1007","volume":"91","author":[{"given":"C. E.","family":"L\u00f3pez-Jorge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"G\u00f3mez-Casares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jim\u00e9nez-Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Garc\u00eda-Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"de la Iglesia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. I.","family":"Heiniger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Molero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,25]]},"reference":[{"key":"1468_CR1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.seminhematol.2010.06.007","volume":"47","author":"S Branford","year":"2010","unstructured":"Branford S, Hughes TP (2010) Practical considerations for monitoring patients with chronic myeloid leukemia. Semin Hematol 47:327\u2013334","journal-title":"Semin Hematol"},{"key":"1468_CR2","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1182\/blood-2010-03-273979","volume":"116","author":"TP Hughes","year":"2010","unstructured":"Hughes TP, Hochhaus A, Branford S, M\u00fcller MC, Kaeda JS, Foroni L et al (2010) Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS). Blood 116:3758\u20133765","journal-title":"Blood"},{"key":"1468_CR3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1182\/blood-2006-01-0092","volume":"108","author":"T Hughes","year":"2006","unstructured":"Hughes T, Deininger M, Hochhaus A, Branford S, Radich J, Kaeda J et al (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108:28\u201337","journal-title":"Blood"},{"key":"1468_CR4","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2008-04-150680","volume":"112","author":"S Branford","year":"2008","unstructured":"Branford S, Fletcher L, Cross NC, M\u00fcller MC, Hochhaus A, Kim DW et al (2008) Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. Blood 112:3330\u20133338","journal-title":"Blood"},{"key":"1468_CR5","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1373\/clinchem.2007.085472","volume":"53","author":"ES Winn-Deen","year":"2007","unstructured":"Winn-Deen ES, Helton B, Van Atta R, Wong W, Peralta J, Wang J et al (2007) Development of an integrated assay for detection of BCR-ABL RNA. Clin Chem 53:1593\u20131600","journal-title":"Clin Chem"},{"key":"1468_CR6","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","volume":"17","author":"J Gabert","year":"2003","unstructured":"Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N et al (2003) Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia\u2014a Europe Against Cancer Program. Leukemia 17:2318\u20132357","journal-title":"Leukemia"},{"key":"1468_CR7","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","volume":"17","author":"E Beillard","year":"2003","unstructured":"Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R et al (2003) Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)\u2014a Europe Against Cancer Program. Leukemia 17:2474\u20132486","journal-title":"Leukemia"},{"key":"1468_CR8","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/leu.2009.168","volume":"23","author":"MC Muller","year":"2009","unstructured":"Muller MC, Cross NCP, Erben P, Schenk T, Hanfstein B, Ernst T et al (2009) Harmonization of molecular monitoring of CML therapy in Europe. Leukemia 23:1957\u20131963","journal-title":"Leukemia"},{"key":"1468_CR9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2353\/jmoldx.2007.060112","volume":"9","author":"Z Jobbagy","year":"2007","unstructured":"Jobbagy Z, Van Atta R, Murphy KM, Eshleman JR, Gocke CD (2007) Evaluation of the Cepheid GeneXpert BCR-ABL assay. J Mol Diagn 9:220\u2013227","journal-title":"J Mol Diagn"},{"key":"1468_CR10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.5858\/2007-131-947-QAOTBT","volume":"131","author":"SD Dufresne","year":"2007","unstructured":"Dufresne SD, Belloni DR, Levy NB, Tsongalis G (2007) Quantitative assessment of the BCR-ABL transcript using the Cepheid Xpert BCR-ABL Monitor assay. Arch Pathol Lab Med 131:947\u2013950","journal-title":"Arch Pathol Lab Med"},{"key":"1468_CR11","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","volume":"27","author":"M Baccarani","year":"2009","unstructured":"Baccarani M, Cortes J, Pane F, Niederwieser D, Saglio G, Apperley J et al (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27:6041\u20136051","journal-title":"J Clin Oncol"},{"key":"1468_CR12","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1158\/1078-0432.CCR-07-1112","volume":"13","author":"RD Press","year":"2007","unstructured":"Press RD, Galderisi C, Yang R, Rempfer C, Willis SG, Mauro MJ et al (2007) A half-log increase in BCR-ABL RNA predicts a higher risk of relapse in patients with chronic myeloid leukemia with an imatinib-induced complete cytogenetic response. Cli Can Res 13:6136\u20136143","journal-title":"Cli Can Res"},{"key":"1468_CR13","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1182\/blood-2010-06-291641","volume":"116","author":"HE White","year":"2010","unstructured":"White HE, Matejtschuk P, Rigsby P, Gabert J, Lin F, Lynn Wang Y et al (2010) Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA. Blood 116:e111\u2013e117","journal-title":"Blood"},{"key":"1468_CR14","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3324\/haematol.2010.034389","volume":"96","author":"JM Cayuela","year":"2011","unstructured":"Cayuela JM, Macintyre E, Darlington M, Abdelali RB, Fund X, Villarese P et al (2011) Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost? Haematologica 96:664\u2013671","journal-title":"Haematologica"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1468-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-012-1468-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-012-1468-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T21:49:31Z","timestamp":1642110571000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-012-1468-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,25]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1468"],"URL":"https:\/\/doi.org\/10.1007\/s00277-012-1468-4","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,25]]}}}